Detalhe da pesquisa
1.
Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes.
Diabet Med
; 36(4): 505-513, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576013
2.
Early vs. standard screening and treatment of gestational diabetes in high-risk women - An attempt to determine relative advantages and disadvantages.
Nutr Metab Cardiovasc Dis
; 29(6): 598-603, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30954416
3.
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.
Nutr Metab Cardiovasc Dis
; 29(5): 421-431, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952574
4.
The role of adipokines in the pathogenesis of gestational diabetes mellitus.
Gynecol Endocrinol
; 35(9): 737-751, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30990092
5.
Italian national guidelines for the screening of gestational diabetes: Time for a critical appraisal?
Nutr Metab Cardiovasc Dis
; 27(8): 717-722, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28755805
6.
Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitus.
Diabetes Obes Metab
; 18(6): 623-7, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865535
7.
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic ß-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
Diabetes Obes Metab
; 18(8): 834-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059816
8.
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study.
Eur J Nutr
; 55(4): 1645-51, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303195
9.
Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials.
Nutr Metab Cardiovasc Dis
; 26(10): 886-92, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27484756
10.
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
Nutr Metab Cardiovasc Dis
; 26(5): 361-73, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27105869
11.
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.
Diabetes Obes Metab
; 17(2): 107-15, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24867662
12.
Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients.
Diabetes Obes Metab
; 17(11): 1085-92, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26250051
13.
Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.
Diabetes Obes Metab
; 17(6): 581-590, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25735400
14.
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy.
Diabetes Obes Metab
; 17(2): 202-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387855
15.
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.
Diabetes Obes Metab
; 17(2): 136-44, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25298165
16.
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.
Nutr Metab Cardiovasc Dis
; 25(10): 898-905, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232910
17.
Rare diseases in clinical endocrinology: a taxonomic classification system.
J Endocrinol Invest
; 38(2): 193-259, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25376364
18.
Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial.
Diabet Med
; 31(10): 1178-84, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24863949
19.
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea.
Diabetes Obes Metab
; 16(5): 403-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199686
20.
Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
Diabetes Obes Metab
; 16(12): 1239-46, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132212